Select for export How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06106-8 PubMed 35348806 Copy citation Copy BibTeX Psychopharmacology 2022-05-31 van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH PubMed Published psilocybin DepressionPharmacologyMystical Experience Other More
Select for export Unraveling the Mysteries of Mental Illness With Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.25414 PubMed 35769681 Copy citation Copy BibTeX Unknown journal 2022-05-26 Sotille R, Singh H, Weisman A, Vida T. Europe PMC Published psilocybinpsilocin DepressionNeuroplasticityReceptor Pharmacology Clinical Trial More
Select for export Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-05-19 National Institute of Mental Health, Czech Republic ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export Magic mushroom extracts in lipid membranes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.bbamem.2022.183957 PubMed 35561790 Copy citation Copy BibTeX Biochimica et Biophysica Acta (BBA) - Biomembranes 2022-05-09 Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H. Europe PMC Published psilocybinpsilocin DepressionAddictionReceptor Pharmacology Other More
Select for export Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-04-28 University of Zurich ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2022.02.624 Copy citation Copy BibTeX Biological Psychiatry 2022-04-27 Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes OpenAlex Published psilocybin DepressionAnxietyClinical Trial Randomized Controlled Trial More
Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674221083868 PubMed 35285280 Copy citation Copy BibTeX Unknown journal 2022-03-11 Kisely S, Connor M, Somogyi AA, Siskind D. Europe PMC Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nsa.2022.100104 PubMed 40656230 Copy citation Copy BibTeX Neuroscience Applied 2022-03-06 Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A Europe PMC Published psilocybin DepressionClinical TrialSafety Clinical Trial More
Select for export Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyg.2022.813746 PubMed 35310225 Copy citation Copy BibTeX Unknown journal 2022-03-03 Sekula AD, Downey L, Puspanathan P. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export Increased low-frequency brain responses to music after psilocybin therapy for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.02.13.480302 Copy citation Copy BibTeX bioRxiv 2022-02-14 Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionBrain ImagingAging Other More
Select for export Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsomega.1c06708 PubMed 35187358 Copy citation Copy BibTeX ACS Omega 2022-02-06 Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S. Europe PMC Published psilocybinpsilocin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export [Are psychedelics fast acting antidepressant agents?] Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00115-021-01255-1 PubMed 35103814 Copy citation Copy BibTeX Unknown journal 2022-01-31 Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M Europe PMC Published psilocybin Depression Other More
Select for export Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1714-9097 PubMed 35045580 Copy citation Copy BibTeX Unknown journal 2022-01-18 Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Systematic Review More
Select for export SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5298/1081-5937-50.03.03 Copy citation Copy BibTeX Biofeedback 2021-12-31 Jeff Tarrant OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Psilocybin may be effective for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.164911 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Psilocybin: a psychedelic alternative to antidepressants? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.169269 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionPharmacologyTreatment-Resistant Depression Other More
Select for export The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100213 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100511 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
